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OBJECTIVES We aimed to study the effects of early successful primary angioplasty for ST-segment
elevation acute myocardial infarction (AMI) on early and late infarct size and left ventricular
(LV) wall characteristics.
BACKGROUND Early reperfusion treatment for AMI preserves LV function, but the effects on early and late
infarct size, end-diastolic wall thickness (EDWT), and segmental wall thickening (SWT) are
not well known.
METHODS In 22 patients with successful primary angioplasty for first AMI, cine–magnetic resonance
imaging (MRI), first-pass perfusion, and delayed-enhancement imaging was performed at
five days and five months. The extent of microvascular obstruction (MO) was evaluated on
perfusion images. Infarct shrinkage was defined as the difference between the volume of
delayed-enhancement at five days and five months. The EDWT and SWT were quantified
on cine-MRI.
RESULTS Infarct shrinkage occurred to the same extent in small and large infarctions [r  0.92; p 
0.001], with a mean decrease of 31% (35  21 g to 24  17 g). Dysfunctional segments
without MO had an increased EDWT at five days compared with remote myocardium (9.2
 1.7 mm vs. 8.4  1.7 mm; p  0.001). At five months, EDWT in these segments became
comparable to the thickness of remote myocardium (7.8  1.6 mm vs. 7.6  1.4 mm; p 
0.60), and SWT improved (21  15% to 40  24%; p  0.001) but remained impaired (40
 24% vs. 71  29%; p  0.001). Segments with MO demonstrated wall thinning at five
months (6.4  1.3 mm vs. 7.6  1.4 mm; p  0.006) and no significant recovery in SWT
(12  14% to 17  20%; p  0.15).
CONCLUSIONS Infarct size decreased by 31%. Segments without MO had early increased wall thickness and
late partial functional recovery. Segments with MO showed late wall thinning and no
functional recovery at five months. (J Am Coll Cardiol 2006;47:40–4) © 2006 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.09.008American College of Cardiology Foundation
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warly restoration of epicardial coronary blood flow reduces
nfarct size in patients with acute myocardial infarction
AMI) and has a beneficial effect on post-infarction myo-
ardial infarct healing and left ventricular (LV) remodeling
1–3). Early reperfusion, however, might also lead to endo-
helial dysfunction and extravasation of fluids to the inter-
titium (4). Understanding the natural course of infarct
ealing and the effect of early reperfusion on ischemic
yocardium might contribute to understanding and devel-
ping new therapies for ischemic heart disease. Recently, it
as shown that contrast-enhanced magnetic resonance
maging (ce-MRI) allows the assessment of myocardial
erfusion, infarct size, and LV wall thickness/function with
ood reproducibility and excellent correlation with histology
n animal models of acute and chronic myocardial infarction
From the *Department of Cardiology, Thoraxcenter, and the †Department of
adiology, Erasmus Medical Center, University Medical Center, Rotterdam, the
etherlands.a
Manuscript received March 20, 2005; revised manuscript received June 1, 2005,
ccepted July 27, 2005.5–11). Therefore, we performed ce-MRI in patients who
uffered AMI and were treated within six hours with
uccessful drug-eluting stent implantation to study the
ffects on early and late infarct size and LV wall
haracteristics.
ETHODS
atient population. We studied 30 patients (25 men, age
3  10 years) admitted to the coronary care unit with first
MI. Patient characteristics are listed in Table 1. Diagnosis
as on the basis of clinical symptoms, ST-segment eleva-
ion on electrocardiogram, and angiographically demon-
trated occlusion of a coronary artery. All vessels were
tented with a drug-eluting stent within 6 h (mean 2.5 h) of
nset of symptoms, resulting in Thrombolysis In Myocar-
ial Infarction flow grade 3 (12). Exclusion criteria con-
isted of any contraindication to MRI. All participants gave
ritten informed consent to the study protocol, which waspproved by the medical ethics committee of the Erasmus
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f 22 patients who had the first MRI scan 5  3 days after
dmission and the second MRI scan 20  7 weeks later.
ight patients did not undergo a second scan: one patient
ied (noncardiac death), two patients had a defibrillator
mplanted, and five patients refused to come back. Angio-
raphic follow-up was performed in eight patients (36%),
nd no in-stent restenosis was seen. In the other patients,
here was no clinical evidence of recurrent myocardial
schemia, and all patients received a drug-eluting stent in
he infarct-related coronary artery, with very low numbers of
estenosis reported (13).
RI protocol. A clinical 1.5-T MRI with a dedicated
ardiac four-element phased-array receiver coil was used for
maging (Signa CV/i, GE Medical Systems, Milwaukee,
isconsin). Baseline and follow-up ce-MRI protocol con-
isted of cine-MRI, first-pass perfusion, and delayed en-
ancement imaging. The cine-MRI was performed with a
teady-state free-precession technique (FIESTA, GE Med-
cal Systems) with the following imaging parameters: 24
emporal phases per slice, field of view (FOV) 32 to 36 cm
32 to 36 cm; rectangular FOV 0.75; repetition time (TR)
.2 to 3.7; time to echo (TE) 1.4; flip angle 45°; matrix 160
128, bandwidth 83 kHz, number of averages 0.75. To
Abbreviations and Acronyms
AMI  acute myocardial infarction
ce-MRI  contrast-enhanced magnetic resonance
imaging
EDWT  end-diastolic wall thickness
ESWT  end-systolic wall thickness
FOV  field of view
LV  left ventricle/ventricular
MO  microvascular obstruction
SWT  segmental wall thickening
TE  time to echo
TR  repetition time
able 1. Patient Characteristics (n  22)
ge (yrs) 52  12
en 16 (73)
moking 15 (68)
iabetes mellitus 1 (5)
ypertension 6 (27)
ypercholesterolemia 5 (23)
amily history of coronary artery disease 12 (55)
reatine kinase peak (IU) 3,112  2,001
nterior infarction 15 (68)
nferior/lateral infarction 7 (32)
bciximab peri-procedural 14 (64)
CE inhibitor baseline/follow-up 1 (5)/18 (82)
eta-blocker baseline/follow-up 3 (14)/22 (100)
lopidogrel 22 (100)
tatin follow-up 20 (91)
SA follow-up 22 (100)
jection fraction 5 days (%) 48  11
jection fraction 5 months (%) 55  9j
alues are presented as (%) or mean  SD.
ACE  angiotensin-converting enzyme; ASA  acetylsalicylic acid.over the entire LV, 9 to 12 consecutive slices of 8 mm were
lanned in short-axis view (gap of 2 mm) on the horizontal
ong axis (four-chamber view) of the LV. First-pass perfu-
ion imaging was performed during 30 to 40 consecutive
eartbeats immediately after administration of gadolinium-
iethylenetriamine penta-acetic acid (DTPA) (0.1 mmol/
g; Magnevist, Schering, Germany; 4 ml/s in an antecubital
ein, followed by 15 ml of saline at 4 ml/s). A special
re-saturation scheme with a notched excitation followed by
segmented gradient-echo/echo-planar readout was used
14) with the following imaging parameters: FOV 32 to 36
m 32 to 36 cm, rectangular FOV 0.75, TR 6.8, inversion
ime 150 to 175 ms, saturation pulse 90°, TE 1.2, echo train
ength 4, number of averages 0.75, bandwidth 125 kHz, flip
ngle 20°, matrix 128  96, slice thickness 8 mm. The
emporal resolution per slice of 120 ms allowed imaging of
ve to eight slices per RR interval (maximum heart rate of
0 beats/min). Perfusion images were planned to cover the
asal, mid, and apical part of the LV in the same orientation
s the cine images. Delayed enhancement imaging was
erformed with a two-dimensional T1-weighted inversion-
ecovery gradient-echo sequence 10 to 20 min after perfu-
ion imaging with the following parameters: FOV 32 to 36
m  32 to 36 cm, rectangular FOV 0.75; slice thickness 8
m, gap 2 mm, TR 7.3, TE 1.6, flip angle 20°, inversion
ulse of 180°, matrix 256  192, number of averages 1,
andwidth 17.9 kHz, inversion time 180 to 275 ms (ad-
usted per patient to null the signal of remote myocardium).
lice locations of the delayed enhancement images were
opied from the cine images.
efinitions and data analysis. Cine, perfusion, and de-
ayed enhancement images were all matched for position
ith anatomical landmarks like papillary muscles and the
nsertion of the right ventricle. To quantify end-diastolic
all thickness (EDWT), end-systolic wall thickness
ESWT), LV volumes, and LV mass, epicardial and endo-
ardial contours were detected automatically and corrected
anually on short-axis cine-MRI images in 16 myocardial
egments per patient with the centerline method (Mass;
edis, Leiden, the Netherlands). Segmental wall thicken-
ng (SWT) was calculated by: (ESWT  EDWT)/EDWT
100. Myocardial segments were considered dysfunctional
f SWT was 45% or less (15). Myocardial perfusion was
valuated qualitatively on first-pass perfusion images and
cored as: 1  no microvascular obstruction (MO) (homo-
eneous enhancement of myocardium), 2  presence of
O (hypoenhanced region). No perfusion study had to be
xcluded from the analysis owing to lack of image quality.
nfarcted myocardium was clearly differentiated from re-
ote myocardium with a delayed enhancement inversion-
ecovery pulse sequence. Infarct size was quantified by
anually tracing the delayed enhanced regions from the
onsecutive two-dimensional slices encompassing the LV.
elayed enhancement volume was multiplied by 1.05 g/ml
o obtain myocardial infarct mass. Total infarct mass was
udged as non-assessable in four baseline scans, because the
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Effects of Early Primary Angioplasty January 3, 2006:40–4egion of delayed enhancement could not be differentiated
learly from the healthy myocardium in all myocardial
egments (breathing artifacts, erroneous electrocardio-
raphic triggering). These data were left out from the
egression analysis.
tatistical analysis. All data are expressed as mean  SD.
egmental data were stratified on baseline perfusion images
n three groups: first, dysfunctional segments without MO;
econd, dysfunctional segments with MO; and third, re-
ote myocardium. One-way analysis of variance was used
or the comparison of EDWT measurements (at five days
nd at five months) between the three groups, followed by
npaired t tests. Two-way analysis of variance with repeated
easures over time was used to compare changes in SWT
etween five days and five months and to evaluate the
ifference in these changes between the three groups.
onferroni correction was applied to adjust for multiple
omparisons. Univariate linear regression analysis was used
o evaluate the relationship between infarct mass at five days
nd five months. Significance was accepted at p  0.05.
ESULTS
yocardial infarct size. Mean infarct size decreased sig-
ificantly with 31%, from 35  21 g at five days to 24 
7 g at five months (p 0.001), which was 26 14% to 20
11% of LV mass. Infarct size decreased relatively to the
ame extent in small and large infarctions (r  0.92; p 
.001) (Fig. 1). Anterior infarctions decreased from a mean
f 36 to 25 g (30% reduction), as much as inferolateral
nfarctions, which decreased from 33 to 22 g (33% reduc-
ion). Remote LV mass decreased slightly but not statisti-
ally significantly from 100 26 g to 94 23 g (p 0.18).
V wall characteristics. Dysfunctional segments without
O had an increased EDWT at five days compared with
igure 1. Relation between myocardial infarct mass at five days and five
onths after acute myocardial infarction (AMI) (solid line). Equation: ym
0.71x  1.5. Dashed line represents the line of unity (i.e., infarct mass
t baseline is infarct mass at follow-up).emote myocardium (9.2  1.7 mm vs. 8.4  1.7 mm; p 
.001) and segments with MO, despite a stented and patent
oronary artery (8.4  1.7 mm; p  0.07) (Fig. 2A). At five
onths, segments without MO had a reduced EDWT
omparable to the thickness of remote segments (7.8  1.6
m vs. 7.6  1.4 mm; p  0.60) (Fig. 2B) and demon-
trated improvement in SWT (21 15% to 40 24%; p
.001), although function remained impaired compared
ith remote myocardium (40  24% vs. 71  29%; p
0.001) (Fig. 3). Segments with MO demonstrated wall
hinning at five months compared with remote segments
6.4  1.3 mm vs. 7.6  1.4 mm; p  0.006) and no
ignificant recovery of SWT (12  14% to 17  20%; p 
.15).
ISCUSSION
n our study of 22 patients who underwent successful
rug-eluting stent implantation within six hours of onset of
ymptoms, we first demonstrated that infarct size decreased
elatively to the same extent in small and large infarctions,
ith a mean decrease of 31%. Second, we observed that
ysfunctional segments without MO exhibited an increased
DWT compared with remote myocardium. These seg-
igure 2. (A) Dysfunctional segments without microvascular obstruction
MO) had an increased end-diastolic wall thickness (EDWT) at five days
ompared with remote myocardium and myocardium with MO. (B) At five
onths, segments with MO demonstrated wall thinning compared with
emote myocardium and myocardium without MO. End-diastolic wall
hickness of myocardium without MO became comparable to remote
yocardium.ents showed a significant improvement in wall thickening.
T
a
s
f
e
I
i
s
m
c
I
o
c
s
n
o
b
e
2
b
c
o
e
w
a
T
t
e
d
d
a
(
w
r
p
i
m
m
M
e
a
f
m
I
m
s
r
t
a
p
o
m
i
s
d
3
a
m
s
a
t
u
e
p
s
p
o
d
(
b
I
p
t
H
r
v
m
i
n
v
o
p
i
t
(
d
c
s
I
f
F
s
f
c
43JACC Vol. 47, No. 1, 2006 Baks et al.
January 3, 2006:40–4 Effects of Early Primary Angioplastyhird, segments with MO, despite a stented coronary
rtery, demonstrated wall thinning at five months and
howed no significant improvement in wall thickening at
ollow-up.
The pathophysiology of infarct healing and LV remod-
ling has been studied in a canine model of AMI (16).
nfarct healing seemed to be an ongoing process, with early
nfarct expansion (four days) followed by infarct resorption,
car formation, and wall thinning (six weeks). Necrotic
yocytes, interstitial edema, hemorrhage, and inflammatory
ells were resorbed and replaced by collagenous scar tissue.
nfarct healing might be further enhanced by repopulation
f the border zones of the infarcted area by circulating stem
ells (17). Remote myocardial mass increased in an animal
tudy of AMI (3), whereas in our study, a small but
onsignificant reduction in remote myocardial mass was
bserved. This observation in our study might be explained
y early and chronic treatment with angiotensin-converting
nzyme inhibition in 18 patients (82%) and beta-blockers in
2 patients (100%).
Studying infarct size reduction in patients has recently
ecome possible with the introduction of high-resolution
e-MRI. Contrast-enhanced MRI allows the differentiation
f necrotic and viable myocardium with delayed-
nhancement imaging, besides the assessment of myocardial
all thickening with cine-MRI and myocardial perfusion
nd MO with first-pass perfusion imaging (3,5,8,11,18,19).
herefore, ce-MRI is a suitable non-invasive imaging tool
o evaluate the natural course of infarct healing and to
valuate stem-cell therapy for AMI. Promising but contra-
ictory results have been reported (20–22). The nonran-
omized Transplantation of Progenitor Cells and Regener-
tion Enhancement in Acute Myocardial Infarction
TOPCARE-AMI) trial studied acute infarct patients who
ere treated with coronary stenting with a mean time of
eperfusion of 23 h, followed by coronary infusion of adult
rogenitor cells at four days. They demonstrated an increase
n ejection fraction of 5% at 4 months and of 9% at 12
onths. Infarct size decreased approximately 20% at 4
igure 3. Dysfunctional myocardial segments without microvascular ob-
truction (MO) demonstrated improved segmental wall thickening at
ollow-up, but function remained impaired compared with remote myo-
ardium. Open bars  five days; solid bars  five months.onths and 34% at 12 months. In the randomized Bone darrow Transfer to Enhance ST-Elevation Infarct Regen-
ration (BOOST) trial, patients were eligible for inclusion if
dmitted within five days of onset of symptoms. Ejection
raction increased by 7% in patients treated with bone-
arrow cells and 1% in patients treated conventionally.
nfarct size decreased in both patient groups by approxi-
ately 30% to 35% in six months. Ingkanisorn et al. (23)
tudied patients with acute or subacute (up to one month)
evascularization therapy and observed an increase in ejec-
ion fraction of 5% and a decrease in infarct size of
pproximately 34% in five months. In the present study,
atients were revascularized within six hours and received
ptimal pharmacological treatment for AMI. An improve-
ent in ejection fraction of 7% was demonstrated, and
nfarct size decreased by 31% in five months. From these
tudies, it might be concluded that there seems to be no
ifference in decrease of infarct size (approximately 30% to
5%) between patients treated with mechanical perfusion
lone or with the combination of infusion of either bone
arrow or adult progenitor cells and mechanical reperfu-
ion. The increase in ejection fraction ranged between
pproximately 5% and 7%, and only in the control group of
he BOOST trial did the ejection fraction remain nearly
nchanged. It remains to be seen whether infarct size or
jection fraction or the combination needs to be taken as the
rimary end point in the investigations of reperfusion
trategies in AMI.
Restoration of epicardial coronary flow by primary angio-
lasty is highly successful in patients with AMI, and the
ccurrence of target vessel restenosis has been reduced
ramatically since the introduction of drug-eluting stents
13); however, the effect of restoration of epicardial coronary
lood flow on ischemic myocardium is not well understood.
n a porcine model of AMI, restoration of myocardial
erfusion was followed by an increase in EDWT presumed
o be due to hyperemia and extravasation of fluids (24,25).
istology of reperfused segments with increased EDWT
evealed massive extra-cellular edema but an intact micro-
asculature (24). We observed, in line with these experi-
ental studies, that segments without MO demonstrated an
ncreased EDWT; however, restoration of epicardial coro-
ary blood flow is not always followed by restored micro-
ascular perfusion. Microvascular obstruction might occur
wing to obstructing microthrombi originating from the
rimary occluding thrombus, microvascular plugging by the
nflux of inflammatory cells, and/or locally emerging
hrombi caused by endothelial damage by oxygen radicals
4,26). In our study, myocardial segments with MO did not
emonstrate an increased EDWT. This was most likely
aused by reduced blood-flow in myocardium with MO and
ubsequently less extravasation of fluids to the interstitium.
nterestingly, these segments demonstrated wall-thinning at
ollow-up, and myocardial contractility remained severely
epressed.
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